{
  "calcform.options.sex.male": "Male",
  "calcform.options.sex.female": "Female",
  "calcform.options.residence.north_america": "North America",
  "calcform.options.treatments.statin.high_intensity.label": "High Intensity",
  "calcform.options.treatments.statin.high_intensity.description": "Atorva â‰¥ 40mg; Rosuva â‰¥ 20 mg",
  "calcform.options.treatments.statin.moderate_intensity.label": "Moderate Intensityg",
  "calcform.options.treatments.statin.moderate_intensity.description": "Atorva 10-20 mg; Rosuva 5-10 mg; Prava 40-80 mg; Lova 40 mg; Fluva 80 mg daily dose; Simva 20-40 mg; Pitava 2-4 mg",
  "calcform.options.treatments.statin.low_intensity.label": "Low Intensity",
  "calcform.options.treatments.statin.low_intensity.description": "Any other dose",
  "calcform.options.treatments.p2y12.clopidogrel": "Clopidogrel",
  "calcform.options.treatments.p2y12.prasugrel": "Prasugrel",
  "calcform.options.treatments.p2y12.ticagrelor": "Ticagrelor",

  "calcform.validation.general.required": "This field is required",
  "calcform.validation.general.invalid_range": "Value must be between {min} and {max} {unit}",
  "calcform.validation.general.diabetes_medications_no_diabetes": "Calculator not valid for diabetes medication without diabetes diagnosis.",
  "calcform.validation.rivaroxaban.mixed_with_antiplatelets": "Calculator not valid for rivaroxaban with other non-aspirin anti-platelets",

  "calcform.patient_details_summary.cad": "CAD",
  "calcform.patient_details_summary.chf": "CHF",
  "calcform.patient_details_summary.cvd": "CVD",
  "calcform.patient_details_summary.pad": "PAD",
  "calcform.patient_details_summary.age": "Age {age}",
  "calcform.patient_details_summary.gender": "{gender, select, male {M} female {F} other {U}}",
  "calcform.patient_details_summary.smoker": "{isSmoker, select, true {Smoker} other {Non-Smoker}} {comm_appendix}",
  "calcform.patient_details_summary.sbp": "SBP {sbp} mmHG",
  "calcform.patient_details_summary.creatinine": "Cr {cr} mg/dl",
  "calcform.patient_details_summary.totalCl": "Total Cholesterol {totalCl} mg/dl",
  "calcform.patient_details_summary.ldlCl": "LDL-C {ldlCl} mg/dl",
  "calcform.patient_details_summary.diabetes": "{diabetes, select, true {Diabetes} other {}}",
  "calcform.patient_details_summary.no_details": "No patient details",

  "calcform.patient_treatments_summary.statin": "Statin ({intensity} {medication})",
  "calcform.patient_treatments_summary.pcsk9": "PCSK9 Inhibitors",
  "calcform.patient_treatments_summary.ezetimibe": "Ezetimibe",
  "calcform.patient_treatments_summary.sglt2": "SGLT2 Inhibitors",
  "calcform.patient_treatments_summary.glp1": "GLP1 Receptor Agonists",
  "calcform.patient_treatments_summary.aspirin": "Aspirin",
  "calcform.patient_treatments_summary.p2y12": "P2Y12Inhibitors ({p2y12})",
  "calcform.patient_treatments_summary.rivaroxaban": "Rivaroxaban",
  "calcform.patient_treatments_summary.no_details": "No current treatment",

  "calcform.footer.button.calculate": "Calculate Risk Score",
  "calcform.footer.button.restore": "Restore",

  "calcform.form.info.provider_to_confirm": "Provider to confirm.",
  "calcform.form.info.calculator_validity": "Calculator only valid with one or more locations of cardiovascular disease.",
  "calcform.form.section_header.patient_details": "Patient details",
  "calcform.form.section_header.current_treatments": "Current treatments",
  "calcform.form.section_subheader.demographics": "Demographics and Lab Results",
  "calcform.form.section_subheader.comorbidities": "Comorbidities",
  "calcform.form.section_subheader.lipid_lowering": "Lipid-lowering",
  "calcform.form.section_subheader.antiplatelet": "AntiPlatelet / Anticoagulant",

  "calcform.form.control.age.label": "Age (years)",
  "calcform.form.control.age.placeholder": "45 - 89 years",
  "calcform.form.control.sex.label": "Sex",
  "calcform.form.control.residence.label": "Residence",
  "calcform.form.control.sbp.label": "Systolic Blood Pressure (mmHg)",
  "calcform.form.control.sbp.placeholder": "100 - 200 mmHg",
  "calcform.form.control.creatinine.label": "Creatinine (mg/dL)",
  "calcform.form.control.creatinine.placeholder": "0.3 - 6.0 mg/dL",
  "calcform.form.control.totalCholesterol.label": "Total Cholesterol (mg/dL)",
  "calcform.form.control.totalCholesterol.placeholder": "100 - 400 mg/dL",
  "calcform.form.control.ldlCholesterol.label": "LDL-Cholesterol (mg/dL)",
  "calcform.form.control.ldlCholesterol.placeholder": "0 - 400 mg/dL",
  "calcform.form.control.cad.label": "Coronary Artery Disease",
  "calcform.form.control.cvd.label": "Cerebrovascular Disease",
  "calcform.form.control.pad.label": "Peripheral Artery Disease",
  "calcform.form.control.atrial_fibrillation.label": "Atrial Fibrillation",
  "calcform.form.control.chf.label": "Congestive Heart Failure",
  "calcform.form.control.diabetes.label": "Diabetes",
  "calcform.form.control.smoking.label": "Current Smoking",
  "calcform.form.control.statin.label": "Statin*",
  "calcform.form.control.statin.warning": "Unable to determine intensity by given statin value ({medication}). Please select one manually.",
  "calcform.form.control.pcsk9.label": "PCSK9 Inhibitor (Alirocumab, Evolocumab)",
  "calcform.form.control.ezetimibe.label": "Ezetimibe",
  "calcform.form.control.sglt2.label": "SGLT2 Inhibitor (e.g. Dapagliflozin, Empagliflozin, etc.)",
  "calcform.form.control.glp1.label": "GLP1 Receptor Agonists (e.g. Semaglutide, Liraglutide, etc.)",
  "calcform.form.control.aspirin.label": "Aspirin",
  "calcform.form.control.p2i12.label": "P2Y12 Inhibitors",
  "calcform.form.control.rivaroxaban.label": "Low-dose Rivaroxaban (2.5 mg)",

  "treatments.form.info.select_treatment": "Select intended treatments to calculate updated estimated risk.",
  "treatments.form.section_header.intended_treatments": "Intended treatments",
  "treatments.form.section_subheader.lipid_lowering": "Lipid-lowering",
  "treatments.form.section_subheader.antiplatelet": "AntiPlatelet / Anticoagulant",
  "treatments.form.section_subheader.diabetes": "Diabetes",

  "treatments.form.control.statin.label": "Statin*",
  "treatments.form.control.pcsk9.label": "PCSK9 Inhibitor (Alirocumab, Evolocumab)",
  "treatments.form.control.ezetimibe.label": "Ezetimibe",
  "treatments.form.control.sglt2.label": "SGLT2 Inhibitor (e.g. Dapagliflozin, Empagliflozin, etc.)",
  "treatments.form.control.glp1.label": "GLP1 Receptor Agonists (e.g. Semaglutide, Liraglutide, etc.)",
  "treatments.form.control.aspirin.label": "Aspirin",
  "treatments.form.control.p2i12.label": "P2Y12 Inhibitors",
  "treatments.form.control.rivaroxaban.label": "Low-dose Rivaroxaban (2.5 mg)",



  "graph.data.label.no_treatment": "Without treatment*",
  "graph.data.label.current_treatment": "With current treatment",
  "graph.data.label.intended_treatment": "With intended treatment",

  "navbar.tabOne": "Risk Score",
  "navbar.tabTwo": "For Patients",
  "navbar.tabThree": "For Providers",

  "patientBanner.details": "{age} years, {gender}, {month}/{day}/{year}",
  "patientBanner.appTitle": "ASCVD Secondary Prevention Risk Calculator",
  "patientBanner.appSubtitle": "10-Year Risk Calculator for Established ASCVD (SMART-REACH)",
  "patientBanner.male": "Male",
  "patientBanner.female": "Female",

  "footer.footnote.statin": "The calculator is not intended to show how risk increases or changes if statin therapy were stopped or was not initiated",
  "footer.note.title": "Please Note",
  "footer.note.text": "This tool is meant to provide estimated 10-year risks and simulate changes on therapy.  Decisions regarding therapy should be made by providers.  Therapy options are displayed for simulation purposes and do not represent therapy recommendations.  Patient eligibility for therapy should be determined by their doctor/provider.  Risk estimates on current therapy and intended therapy based on clinical-trial based relative risk reductions.  See \"For Providers\" Tab for more information.",
  "footer.bp.title": "Blood Pressure",
  "footer.bp.text": "Blood pressures are used to calculate 10-year risk. Relative risk reductions for blood pressure lowering depend on starting blood pressure and the patient population. Current guideline-recommended BP goals for patients with established cardiovascular disease are <130/<80.",
  "footer.smoking.title": "Smoking",
  "footer.smoking.text": "Smoking status used to calculate 10-year risk. Quitting smoking will lower risk. The impact of smoking cessation on 10-year risk depends on duration since quitting.",
  "footer.about.title": "About the Score",
  "footer.about.text": "The SMART-REACH score provides 10-year risk of cardiovascular events in patients with established cardiovascular disease. See provider tab for more details. Kaasenbrood L et al. J Am Heart Assoc 2018;7:e009217",

  "message.simple": "A simple message.",
  "message.argument": "Hi, {name}! ðŸ‘‹",
  "message.plural": "{count, plural, one {# item} other {# items}}",
  "message.select": "{gender, select, male {Mr} female {Mrs} other {User}}",
  "message.text-format": "Hi, <b>John</b>!",
  "message.number-format": "Formatted number: {num, number, ::K}",
  "message.currency-format": "Formatted currency: {amount, number, ::currency/USD}"
}
